港股市场个股详情

01530 三生制药

添加自选

6.550
-0.250-3.68%

午间休市 05/06 11:58 (北京)

159.75亿总市值9.34市盈率TTM

三生制药股票讨论区

登录发表评论

Moomoo AI

03/18 09:08

3SBio Inc.'s lower P/E ratio is due to its forecasted growth being less than the wider market. The potential for earnings improvement may not justify a higher P/E ratio, forming a barrier for the share price.

Investors Don't See Light At End Of 3SBio Inc.'s (HKG:1530) Tunnel

Moomoo AI

01/24 15:50

Despite a recent drop, 3SBio's strong financials and high ROE could boost stock value long term. Significant earnings growth due to substantial profit reinvestment, though future growth may slow.

Could The Market Be Wrong About 3SBio Inc. (HKG:1530) Given Its Attractive Financial Prospects?

Moomoo AI

2023/12/29 07:33

Analyst indicates that the investment risk in 3SBio is kept in check by net cash and EBIT growth. Even though managing debt could be challenging as free cash flow was only 46% of EBIT recently, the company's financials are still strong.

3SBio (HKG:1530) Seems To Use Debt Rather Sparingly

Moomoo AI

2023/12/08 06:19

3SBio, with EPS growth and increased EBIT margins, is defined as a growing business. High level of insider ownership is deemed positive, aligning with shareholders' interests. Yet, the market valuation of it remains unanalysed.

3SBio (HKG:1530) Ticks All The Boxes When It Comes To Earnings Growth

Moomoo AI

2023/11/14 06:44

Despite positive revenue and earnings growth, 3SBio's falling share price signals potential lack of investor faith or unfulfilled market expectations.